Context: Meta-analyses are commonly performed on quasi-experimental studies in medical education and other applied field settings, with little or no apparent concern for biases and confounds present in the studies synthesised. The implicit assumption is that the biases and confounds are randomly distributed across the studies and are averaged or cancelled out by the synthesis.
Objectives: We set out to consider the possibility that the results and conclusions of meta-analyses in medical education are subject to biases and confounds and to illustrate this possibility with a re-examination of the studies synthesised in an important, recently published meta-analysis of problem-based learning.
Methods: We carefully re-examined the studies in the meta-analysis. Our aims were to identify obvious biases and confounds that provided plausible alternative explanations of each study's results and to determine whether these threats to validity were considered and convincingly ruled out as plausible rival hypotheses.
Results: Ten of the 11 studies in the meta-analysis used quasi-experimental designs; all 10 were subject to constant biases and confounds that favoured the intervention condition. Threats to validity were not ruled out in the individual studies, nor in the meta-analysis itself.
Conclusions: Our re-examination of the results and conclusions of the meta-analysis illustrates our concerns about the validity of meta-analyses based primarily on quasi-experimental studies. Our tentative conclusion is that the field of medical education might be better served in most instances by systematic narrative reviews that describe and critically evaluate individual studies and their results in light of threats to their validity.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1365-2923.2008.03144.x | DOI Listing |
J Exp Psychol Gen
January 2025
Department of Cognitive and Psychological Sciences, Brown University.
Faces-the most common and complex stimuli in our daily lives-contain multidimensional information used to infer social attributes that guide consequential behaviors, such as deciding who to trust. Decades of research illustrates that perceptual information from faces is processed holistically. An open question, however, is whether goals might impact this perceptual process, influencing the encoding and representation of the complex social information embedded in faces.
View Article and Find Full Text PDFJ Evol Biol
January 2025
ISTA (Institute of Science and Technology Austria), Am Campus 1, 3400 Klosterneuburg, Austria.
Polymorphic short insertions and deletions (INDELs ≤ 50 bp) are abundant, although less common than single nucleotide polymorphisms (SNPs). Evidence from model organisms shows INDELs to be more strongly influenced by purifying selection than SNPs. Partly for this reason, INDELs are rarely used as markers for demographic processes or to detect divergent selection.
View Article and Find Full Text PDFHeart Rhythm O2
December 2024
Department of Cardiology, Geisinger Medical Center, Danville, Pennsylvania.
Background: Ventricular tachycardia ablation (VTA) is an important treatment option for ventricular tachycardia, with increasing use across all age groups. However, age-related differences in outcomes remain a concern.
Objective: This study aimed to investigate age-related trends in VTA procedures and their associated adverse events across the United States from 2011 to 2021.
Expert Rev Pharmacoecon Outcomes Res
January 2025
IQVIA, Durham, NC.
Introduction: The 2022 Inflation Reduction Act (IRA) is expected to result in lower drug prices for Medicare beneficiaries in the United States (US). The Centers for Medicare & Medicaid Services (CMS) released the most recent draft guidance for the Medicare Drug Price Negotiation (DPN) program in May 2024.
Areas Covered: In August 2023, the list of 10 drugs selected for the DPN were published and the first round of negotiations are now complete.
Lancet Infect Dis
January 2025
Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland; Médecins Sans Frontières, Geneva, Switzerland; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Division of Tropical and Humanitarian Medicine, Geneva University Hospitals, Geneva, Switzerland. Electronic address:
Background: Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis, particularly in Asia and Africa, where HEV genotypes 1 and 2 are prevalent. Although a recombinant vaccine, Hecolin, is available, it has not been used to control outbreaks. The licensed three-dose regimen might pose challenges for it to be an impactful outbreak control tool.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!